Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Gill

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
European Urology|October 6, 2022
Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82Mark A Rubin, Mahul B Amin, Eva Compérat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2021
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapyAsanka R Wijetunga, Terence C Chua, Christopher B Nahm, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2010
Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in miceWilliam S Stevenson, Craig D Hyland, Jian-Guo Zhang, et al.
Annals of Diagnostic Pathology|February 21, 2019
Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 casesKristyna Pivovarcikova, Petr Martinek, Petr Grossmann, et al.
Blood Advances|April 9, 2020
LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphomaColm Keane, Soi C Law, Clare Gould, et al.
The Journal of Pathology|February 1, 2024
Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinomaBraydon Meyer, Clare Stirzaker, Sonny Ramkomuth, et al.
Histopathology|November 20, 2025
WHO classification of skin tumours: key updates in the fifth editionGabrielle Goldman-Lévy, Raymond Barnhill, Boris C Bastian, et al.
Nature|May 19, 2022
Neoantigen quality predicts immunoediting in survivors of pancreatic cancerMarta Łuksza, Zachary M Sethna, Luis A Rojas, et al.
Hereditary Cancer in Clinical Practice|May 5, 2022
Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitalsJulia Steinberg, Priscilla Chan, Emily Hogden, et al.
The British Journal of Surgery|April 25, 2024
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN studyJames Lucocq, Jake Hawkyard, Beate Haugk, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
European Urology|October 6, 2022
Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82Mark A Rubin, Mahul B Amin, Eva Compérat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2021
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapyAsanka R Wijetunga, Terence C Chua, Christopher B Nahm, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2010
Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in miceWilliam S Stevenson, Craig D Hyland, Jian-Guo Zhang, et al.
Annals of Diagnostic Pathology|February 21, 2019
Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 casesKristyna Pivovarcikova, Petr Martinek, Petr Grossmann, et al.
Blood Advances|April 9, 2020
LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphomaColm Keane, Soi C Law, Clare Gould, et al.
The Journal of Pathology|February 1, 2024
Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinomaBraydon Meyer, Clare Stirzaker, Sonny Ramkomuth, et al.
Histopathology|November 20, 2025
WHO classification of skin tumours: key updates in the fifth editionGabrielle Goldman-Lévy, Raymond Barnhill, Boris C Bastian, et al.
Nature|May 19, 2022
Neoantigen quality predicts immunoediting in survivors of pancreatic cancerMarta Łuksza, Zachary M Sethna, Luis A Rojas, et al.
Hereditary Cancer in Clinical Practice|May 5, 2022
Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitalsJulia Steinberg, Priscilla Chan, Emily Hogden, et al.
The British Journal of Surgery|April 25, 2024
Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN studyJames Lucocq, Jake Hawkyard, Beate Haugk, et al.
Pageof 10